Poly(Adenosine Diphosphate-Ribose) Polymerase Inhibition as Maintenance Treatment for SCLC: The Search Must Continue. Huddar P, Califano R. J Thorac Oncol 2021;16:1236-1238.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Huddar P, Califano R. Poly(Adenosine Diphosphate-Ribose) Polymerase Inhibition as Maintenance Treatment for SCLC: The Search Must Continue. J Thorac Oncol 2021;16:1236-1238.
PMID: 34304849